H021 Enteric-coated Tablets Low-dose Group for crohn disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jun 2026: Trial registered, NCT07677514

The trials

NCT07677514: A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

State
Not started
Phase
Phase 2
People
156 planned
Started
12 Jul 2026
Primary completion
12 Oct 2026
Arms
H021 Enteric-coated Tablets Low-dose Group
Results
None posted
  1. 30 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.